Avid Bioservices, Inc. (NASDAQ: CDMO) Q1 2021 earnings call dated Sep. 01, 2020 Corporate Participants: Tim Brons -- Investor Relations Nicholas Green -- President & Chief
Avid Bioservices, Inc. (CDMO) Q1 2021 Earnings Call Transcript
Categories
Health Care
Aimmune Therapeutics Inc (AIMT) Q2 2020 Earnings Call Transcript
Aimmune Therapeutics Inc (NASDAQ: AIMT) Q2 2020 earnings call dated July 30, 2020 Corporate Participants: DeDe Sheel -- Vice President of Investor Relations
Medtronic (MDT) revisits business strategy even as recovery gathers steam
https://www.youtube.com/watch?v=ukh0vaOtvBw For Medtronic plc (NYSE:MDT), the last two quarters were disappointing as healthcare institutions postponed routine medial procedures and channeled their resources
Will da Vinci power help Intuitive Surgical (ISRG) beat COVID blues?
Being part of a rapidly growing industry and having a successful business model can be a winning combination in difficult times like
Medtronic PLC (MDT) Q1 2021 Earnings Call Transcript
Medtronic PLC (NYSE: MDT) Q1 2021 earnings call dated Aug. 25, 2020 Corporate Participants: Ryan Weispfenning -- Vice President, Investor Relations Geoffrey S. Martha -- Chief
Should you buy Liminal BioSciences (LMNL) stock?
So far, COVID-19 has claimed more than 800,000 lives all over the world. The biomedical community is rigorously working on finding an
Medtronic (MDT) Earnings: 1Q21 Key Numbers
Medtronic plc (NYSE:MDT) reported first quarter 2021 earnings results today. Worldwide revenue decreased 13% to $6.5 billion. GAAP net income was $487
Stable demand should help PetMed (PETS) emerge stronger from pandemic
PetMed Express (NASDAQ: PETS) has been around for a long time, expanding its foothold in the lucrative pet care market at a
Agilent Technologies Inc. (A) Q3 2020 Earnings Call Transcript
Agilent Technologies Inc (NYSE: A) Q3 2020 earnings call dated Aug. 18, 2020 Corporate Participants: Ankur Dhingra -- Vice President of Investor Relations Mike
CureVac (CVAC): Another COVID-19 stock that attracted investors
In recent times, investors have been betting on the biotech companies that are in the race to develop the COVID-19 vaccine. The
Veru Inc. (VERU) Q3 2020 Earnings Call Transcript
Veru Inc. (NASDAQ: VERU) Q3 2020 earnings call dated Aug. 13, 2020 Corporate Participants: Samuel Fisch -- Director, Investor Relations Mitchell Steiner -- Chairman, President, and
Is Altimmune (ALT) stock a buy right now?
A lot of stocks in the biotech space have skyrocketed this year after their announcements and advances in finding a vaccine or
Biocept Inc. (BIOC) Q2 2020 Earnings Call Transcript
Biocept Inc. (NASDAQ: BIOC) Q2 2020 earnings call dated Aug. 12, 2020 Corporate Participants: Jody Cain -- Investor Relations Michael W. Nall -- President and Chief
Biocept (BIOC) revenue drops 23% in Q2; loss narrows
Biocept (NASDAQ: BIOC) reported a narrower loss in the second quarter of 2020. The company's revenue declined by 23% year-over-year to $917,000,
Infographic: How SmileDirectClub (SDC) performed in Q2 2020
SmileDirectClub Inc. (NASDAQ: SDC) reported second quarter 2020 earnings results today. Total revenue was $107 million compared to $195 million in the
Lemonade Inc. (LMND) Q2 2020 Earnings Call Transcript
Lemonade Inc. (NYSE: LMND) Q2 2020 earnings call dated Aug. 12, 2020 Corporate Participants: Yael Wissner-Levy -- Vice President, Communications Daniel Schreiber -- Co-Founder, Chief Executive
Novavax (NVAX) stock tumbles despite beating bottom line estimates in Q2
After Novavax (NASDAQ: NVAX) reported its progress on developing the COVID-19 vaccine at the end of February, the shares of the company
Aurinia Pharmaceuticals Inc. (AUPH) Q2 2020 Earnings Call Transcript
Aurinia Pharmaceuticals Inc (NASDAQ: AUPH) Q2 2020 earnings call dated Aug. 11, 2020 Corporate Participants: Glenn Schulman -- Senior Vice President, Corporate Communications and
10x Genomics, Inc. (TXG) Q2 2020 Earnings Call Transcript
10x Genomics, Inc. (NASDAQ: TXG) Q2 2020 earnings call dated Aug. 11, 2020 Corporate Participants: Eric Jaschke -- Director of Investor Relations & Strategic
Inovio (INO) aims to produce 100 million doses of COVID-19 vaccine in 2021
Shares of INOVIO (NASDAQ: INO) were down over 23% on Tuesday, a day after the company reported second quarter 2020 earnings results
Trxade launches integrated COVID-19 risk assessment tool for corporate clients
Integrated drug procurement firm Trxade Group (NASDAQ: MEDS) on Tuesday launched a one-of-its-kind platform that brings together various services such as COVID-19